Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17

View through CrossRef
Abstract Metalloproteases play a complex role in tumor progression. While the activity of some ADAM, ADAMTS and matrix metalloproteases (MMPs) seems to be protumorigenic, the activity of others seems to prevent tumor progression. The identification of the array of substrates of a given metalloprotease (degradome) seems an adequate approach to predict the effect of the inhibition of a metalloprotease in tumors. Here, we present the proteomic identification of a novel substrate for ADAM10 and -17. We used SILAC (Stable Isotope Labeling by Amino acids in Cell culture), a proteomic technique based on the differential metabolic labeling of cells in different conditions. This was applied to MCF7 cells derived from an invasive mammary tumor, and the same cells expressing shRNAs that knock down ADAM10 or -17. Following this approach, we have identified C4.4A as a substrate to both metalloproteases. Since C4.4A is likely involved in tumor invasion, these results indicate that the cleavage of C4.4A by ADAM10 and ADAM17 contributes to tumor progression.
Title: Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17
Description:
Abstract Metalloproteases play a complex role in tumor progression.
While the activity of some ADAM, ADAMTS and matrix metalloproteases (MMPs) seems to be protumorigenic, the activity of others seems to prevent tumor progression.
The identification of the array of substrates of a given metalloprotease (degradome) seems an adequate approach to predict the effect of the inhibition of a metalloprotease in tumors.
Here, we present the proteomic identification of a novel substrate for ADAM10 and -17.
We used SILAC (Stable Isotope Labeling by Amino acids in Cell culture), a proteomic technique based on the differential metabolic labeling of cells in different conditions.
This was applied to MCF7 cells derived from an invasive mammary tumor, and the same cells expressing shRNAs that knock down ADAM10 or -17.
Following this approach, we have identified C4.
4A as a substrate to both metalloproteases.
Since C4.
4A is likely involved in tumor invasion, these results indicate that the cleavage of C4.
4A by ADAM10 and ADAM17 contributes to tumor progression.

Related Results

Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation
Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation
AbstractBone resorption is driven through osteoclast differentiation by macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-Β ligand (RANKL)...
Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma
Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma
Introduction Tumor surface matrix metalloproteases ADAM10 and ADAM17 are associated with poor outcomes in multiple malignancies. We previously showed that these prot...
ADAM17 promotes the metastasis of hepatocellular carcinoma via upregulation MMP21
ADAM17 promotes the metastasis of hepatocellular carcinoma via upregulation MMP21
Abstract Background The upregulation of ADAM17 has been reported to be associated with invasion and metastasis in various tumors, however the molecular mechanism of ADAM17 ...
ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21
ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21
Abstract Background: The upregulation of ADAM17 has been reported to be associated with invasion and metastasis in various tumors, however the molecular mechanism of ADAM17...
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
The effect of miRNAs and MALAT1 related with the prognosis of Her-2 positive breast cancer patients with lymph node metastasis
Abstract Background: To analyze and screen the miRNAs associated with lymph node metastasis of breast cancer (BC), and to explore the roles of these miRNAs in the prolifera...
A disintegrin and metalloproteinase (ADAM)‐mediated ectodomain shedding of ADAM10
A disintegrin and metalloproteinase (ADAM)‐mediated ectodomain shedding of ADAM10
AbstractA disintegrin and metalloproteinase (ADAM) 10 is a type I transmembrane glycoprotein responsible for the ectodomain shedding of a range of proteins including the amyloid pr...
Inhibition of ADAM10 and 8 reduces transendothelial migration of the monocytic cell line THP1 in vitro (P5066)
Inhibition of ADAM10 and 8 reduces transendothelial migration of the monocytic cell line THP1 in vitro (P5066)
Abstract Metalloproteases of the A Disintegrin And Metalproteases (ADAM) family are important molecular mediators of inflammation. ADAMs participate at all stages of...
Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide
Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide
AbstractAcute lung injury (ALI) is associated with increased vascular permeability, leukocyte recruitment, and pro‐inflammatory mediator release. We investigated the role of the me...

Back to Top